CVS Health Corporation (CVS): Price and Financial Metrics
CVS Health Corporation (CVS)
Today's Latest Price: $58.60 USD
Updated Mar 27 12:00am
Add CVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 3 in Medical - Drug Stores
See all "A" rated Strong Buy stocks
CVS Stock Summary
- CVS HEALTH Corp's market capitalization of $70,881,078,608 is ahead of 98% of US-listed equities.
- CVS HEALTH Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.67% of US equities in our set.
- Over the past twelve months, CVS has reported earnings growth of 198.86%, putting it ahead of 93.76% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to CVS HEALTH Corp are MDLZ, AXP, BUD, TMUS, and HDB.
- CVS's SEC filings can be seen here. And to visit CVS HEALTH Corp's official web site, go to www.cvshealth.com.
CVS Stock Price Chart More Charts
CVS Price/Volume Stats
| Current price | $58.60 | 52-week high | $77.03 |
| Prev. close | $58.31 | 52-week low | $51.72 |
| Day low | $55.82 | Volume | 15,034,000 |
| Day high | $59.78 | Avg. volume | 10,654,845 |
| 50-day MA | $65.70 | Dividend yield | 3.41% |
| 200-day MA | $64.78 | Market Cap | 76.42B |
CVS Health Corporation (CVS) Company Bio
CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $58.60 | $207.28 | 255% |
We started the process of determining a valid price forecast for CVS HEALTH Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that CVS HEALTH Corp ranked in the 72th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of CVS HEALTH Corp, consider:
- The company's balance sheet shows it gets 46% of its capital from equity, and 54% of its capital from debt. Its equity weight surpasses that of merely 13.28% of free cash flow generating stocks in the Healthcare sector.
- CVS HEALTH Corp's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 5.16% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 249% |
| 1% | 252% |
| 2% | 255% |
| 3% | 259% |
| 4% | 262% |
| 5% | 266% |
BLFS, QDEL, ALXN, LXRX, and OMI can be thought of as valuation peers to CVS, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...